Where does RAN Biotechnologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), RAN Biotechnologies, Inc. ranks #49,933 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does RAN Biotechnologies, Inc. hold?

RAN Biotechnologies, Inc. holds 5 US utility patents granted between 2018 and 2023, spanning 11 technology areas.

What is RAN Biotechnologies, Inc.'s Innovation Score?

RAN Biotechnologies, Inc. has an Innovation Score of 35.1 out of 100 (top 50% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is RAN Biotechnologies, Inc.'s patent grant rate increasing or decreasing?

RAN Biotechnologies, Inc.'s recent grant velocity is +300% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for RAN Biotechnologies, Inc.'s patents?

RAN Biotechnologies, Inc.'s patents average 17.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the RAN Biotechnologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

RAN Biotechnologies, Inc.

Q: What technology areas does RAN Biotechnologies, Inc. focus on?

RAN Biotechnologies, Inc.'s top technology area is B82Y (Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures) with 2 patents. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 11 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B82Y (Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, RAN ranks #49,933 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 11 technology areas.

#49,933
of 49,997 US assignees by volume: Top 50%
by Innovation Score (35.1/100): 17.6
avg claims per patent: +300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R49933 · US Corporation #49,933 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,933/49,997
PHOTO-FINISH Rahan Meristem (1998)
CPC-FOCUS B82Y · 11 areas
INNOV-THIN 35.1/100
CLAIMS-RICH 17.6 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +300% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rahan Meristem (1998) Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
RAN Biotechnologies · this assignee

35
3D Lighting… · lowest

7

What this shows RAN's Innovation Score is 35.1/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where RAN's grants concentrate

RAN Biotechnologies, Inc. is a focused PatentsView assignee: 11 CPC subclasses with 40% of grants classified under B82Y (Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures). By volume, RAN sits between Rahan Meristem (1998) Ltd and Rauch Landmaschinenfabrik GMBH.

RAN's three-year grant acceleration

RAN Biotechnologies, Inc. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Rahan Meristem (1…

5
Raicam Driveline…

5
Raleigh Tackle

5
Ramaxel Technolog…

5
Raphas

5
Rapid Oxygen

5
Rational Internat…

5
Rauch Landmaschin…

5
RAN Biotechnologi… ◀

5

What this shows RAN holds 5 patents at rank #49,938, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near RAN

By rank, the assignees closest to #49,938 in granted patent volume.

Leaders in B82Y (Specific Uses OR Applications OF Nanostructures)

Other assignees with the most granted patents in RAN's primary technology class.

RAN's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

RAN Biotechnologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	20.0%
2020	1	20.0%
2021	1	20.0%
2022	1	20.0%
2023	1	20.0%

Which technologies does RAN Biotechnologies, Inc. patent most?

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

C07K - Peptides 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

C02F - Treatment OF Water, Waste Water, Sewage, OR Sludge 2

Y02W - Climate Change Mitigation Technologies Related TO Wastewater Treatment OR Waste Management 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 2

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 1

Top 11 of 11 technology areas

Where it ranks

Overall rank by patents

#49,933

of 49,997 tracked assignees

Innovation Score

35.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

RAN Biotechnologies, Inc.'s patent record in context - here's where to go next.

RAN Biotechnologies, Inc.'s lead technology class is B82Y (Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures), 40% of its portfolio - see every assignee active in that class. Explore B82Y
Ranked #49,933 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare RAN Biotechnologies, Inc. against Rahan Meristem (1998) Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.